Drug Treatment Center

FDA Approves Valcyte(R) (valganciclovir hydrochloride) to Prevent - MSN Money
NUTLEY, N.J., Aug. 31 /PRNewswire-FirstCall/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Valcyte(R) (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV

FDA Approves Valcyte(R) (valganciclovir hydrochloride) to Prevent - MSN Money
NUTLEY, N.J., Aug. 31 /PRNewswire-FirstCall/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Valcyte(R) (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV

This entry was posted on Monday, August 31st, 2009 at 9:20 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.